In patients with tumors, apart from activating T cell maturation and priming, post-translational modification of chemokines mediated by DPP4 negatively regulates lymphocyte trafficking, and its inhibition enhances T cell migration and tumor immunity by preserving the functional chemokine CXCL10 (35). This evidence concerns the gene DPP4 and neoplasm.